日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

    《2011STS/SCA更新心臟外科血液保護臨床指南》內(nèi)容簡介：

    Background. Practice guidelines reflect published liter-ature. Because of the ever changing literature base, it isnecessary to update and revise guideline recommenda-tions from time to time. The Society of Thoracic Surgeonsrecommends review and possible update of previouslypublished guidelines at least every three years. Thissummary is an update of the blood conservation guide-line published in 2007.

    《2011STS/SCA更新心臟外科血液保護臨床指南》內(nèi)容預覽：

    Routine addition of P2Y12 inhibitors to aspirin therapy early after coronary artery bypass graft （CABG） mayincrease the risk of reexploration and subsequent operation and is not indicated based on availableevidence except in those patients who satisfy criteria for ACC/AHA guideline-recommended dualantiplatelet therapy （eg, patients presenting with acute coronary syndromes or those receiving recentdrug eluting coronary stents）。

    III （B）

    It is reasonable to use preoperative ** （EPO） plus iron, given several days before cardiacoperation, to increase red cell mass in patients with preoperative anemia, in candidates for operation whorefuse transfusion （eg, Jehovah's Witness）， or in patients who are at high risk for postoperative anemia.However, chronic use of EPO is associated with thrombotic cardiovascular events in renal failure patientssuggesting caution for this therapy in individuals at risk for such events （eg, coronary revascularizationpatients with unstable symptoms）。

    IIa （B）

    Recombinant human ** （EPO） may be considered to restore red blood cell volume in patientsalso undergoing autologous preoperative blood donation before cardiac procedures. However, no large-scale safety studies for use of this agent in cardiac surgical patients are available, and must be balancedwith the potential risk of thrombotic cardiovascular events （eg, coronary revascularization patients withunstable symptoms）。

    點擊下載***：《2011STS/SCA更新心臟外科血液保護臨床指南》